Simultaneous binding of bFGF to both FGFR and integrin maintains properties of primed human induced pluripotent stem cells-Reference-Cited by-同舟云学术

Simultaneous binding of bFGF to both FGFR and integrin maintains properties of primed human induced pluripotent stem cells

Published:2024-03 Issue: Volume:25 Page:113-127
ISSN:2352-3204
Container-title:Regenerative Therapy
language:en
Short-container-title:Regenerative Therapy

Author:

Cheng Yu-Shen^ORCID,Taniguchi Yukimasa^ORCID,Yunoki Yasuhiro^ORCID,Masai Satomi^ORCID,Nogi Mizuho^ORCID,Doi Hatsuki,Sekiguchi Kiyotoshi,Nakagawa Masato^ORCID

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Developmental Biology,Biomedical Engineering,Biomaterials

Reference38 articles.

1. Induction of pluripotent stem cells from adult human fibroblasts by defined factors;Takahashi;Cell,2007

2. Embryonic stem cell lines derived from human blastocysts;Thomson;Science,1998

3. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells;Nakagawa;Sci Rep,2014

4. Feeder-free growth of undifferentiated human embryonic stem cells;Xu;Nat Biotechnol,2001

5. Chemically defined conditions for human iPSC derivation and culture;Chen;Nat Methods,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of cell signaling profiles induced by DNA aptamer-based FGFR1 agonist;Analytical Sciences;2024-09-09

2. FGF1 Suppresses Allosteric Activation of β3 Integrins by FGF2: A Potential Mechanism of Anti-Inflammatory and Anti-Thrombotic Action of FGF1;Biomolecules;2024-07-23

3. FGF2 binds to the allosteric site (site 2) and activates integrin αIIbβ3 and FGF1 binds to site 2 but suppresses integrin activation by FGF2: A potential mechanism of anti-thrombotic action of FGF1;2024-04-18

4. FGF2 binds to the allosteric site (site 2) and activates αvβ3 integrin and FGF1 binds to site 2 but suppresses integrin activation by FGF2: a potential mechanism of anti-inflammatory action of FGF1;2024-04-18

5. FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist;Cells;2024-02-07